Sleep apnea common in atrial fibrillation patients

September 11, 2017, Umea University

A study involving cardiac patients at the University Hospital of Umeå shows that over 80 percent of patients treated for atrial fibrillation also have sleep apnea - a condition with pauses in breathing during sleep. The study, presented in a dissertation at Umeå University, indicates that the prevalence of sleep apnea is not affected by electrical cardioversion.

"The results of our study emphasises the importance of examining if with cardiac arrhythmia patients also suffer from . Previous studies show that the treatment of atrial can be improved if the patient is simultaneously treated for sleep apnea," says Niklas Höglund, doctoral student at the Department of Public Health and Clinical Medicine.

Atrial fibrillation is a condition of and can be treated using electrical cardioversion, a treatment converting the heart rhythm through electrical shock. In the current study, carried out at the University Hospital of Umeå, 23 patients who needed electric cardioversion treatment for atrial fibrillation were offered sleep apnea evaluation before and after the treatment. Neither of the patients in the study had a previously known sleep apnea.

The results showed that 74 percent of the participants had while 26 percent had central sleep apnea. Five individuals in the study had both obstructive and central sleep apnea. The follow-up showed that electrical cardioversion treatment for atrial fibrillation did not affect the prevalence of sleep apnea.

Obstructive sleep apnea is a condition with pauses in breathing caused by blockages in the upper airways. Central sleep apnea is caused by signals from the brain to breathing muscles ceasing during short periods. Previous research has shown a connection between sleep apnea and an increased risk of cardiovascular disease. Obstructive sleep apnea can be treated by the patient wearing a CPAP (continuous positive airway pressure) mask during sleep, providing mechanical breathing aid. Another option is using a dental splint that prevents the tongue to fall back and block the airways. Life style changes such as weightloss and reduced alcohol consumption can also have an effect.

"Obstructive sleep apnea contributes to the increase of atrial fibrillation by generating a negative pressure in the chest while breathing through closed airways, which affects the heart's atria. Furthermore, lack of oxygen, increased carbon dioxide levels in the blood and secretion of stress hormones can also lead to the development of ," explains Niklas Höglund.

Niklas Höglund grew up in Jakobstad in Finland. He got his Degree of Master of Science in Medicine at Uppsala University in 1995. Niklas Höglund is a specialist in general medicine and cardiology and is now senior physician at the Arrhythmia Clinic at the Heart Centre at the University Hospital of Umeå. His main field of work is invasive arrhythmia .

Explore further: Diagnosing sleep apnea

Related Stories

Diagnosing sleep apnea

August 29, 2017
Dear Mayo Clinic: Based on my snoring and from everything I've read, I think I may have sleep apnea. But I don't want to spend a night at the hospital for sleep testing. Is there an easier way to know if I have sleep apnea? ...

Sleep apnea may raise heart risks in people with pacemakers

May 5, 2016
(HealthDay)—People with heart pacemakers and sleep apnea are at much greater risk for a dangerous heart rhythm disorder called atrial fibrillation, a new study suggests.

Videotaping sleepers raises CPAP use

July 24, 2017
(HealthDay)—A video may be worth a thousand words for someone with sleep apnea.

Sleep-disordered breathing patients at greater risk for atrial fibrillation

December 9, 2015
Sleep-disordered breathing often predicts the development of atrial fibrillation (AF) in older men, according to U.S. researchers.

Sleep apnea treatment may reverse unhealthy brain changes

September 15, 2015
(HealthDay)—Sleep apnea treatment may reverse changes in brain stem activity associated with increased risk of heart disease, a new study suggests.

Atrial fibrillation recurrence lower with sleep apnea treatment

April 20, 2015
The use of continuous positive airway pressure was associated with a significant reduction in the recurrence of atrial fibrillation in patients with obstructive sleep apnea, according to an analysis of data from past research ...

Recommended for you

Sleep apnea, congenital heart disease may be deadly mix for hospitalized infants

September 17, 2018
Infants often aren't screened for sleep apnea, but a new study suggests the disorder may be tied to an increased risk of death in infants with congenital heart disease.

Sleep deficiency increases risk of a motor vehicle crash

April 4, 2018
Excessive sleepiness can cause cognitive impairments and put individuals at a higher risk of motor vehicle crash. However, the perception of impairment from excessive sleepiness quickly plateaus in individuals who are chronically ...

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms

March 13, 2018
Researchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between ...

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.